Cadence gets option to buy Incline Therapeutics; terminated
Cadence Pharmaceuticals Inc. has agreed to invest $3.5mm in fellow hospital-focused pharma company Incline Therapeutics Inc. for the exclusive option to acquire the company in the next few years for an amount that will not exceed $135mm.
- Medical Devices
- Specialty Pharmaceuticals
- Includes Equity
- Includes M&A Option
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.